2,561 results on '"Bartenstein, Peter"'
Search Results
2. Assessment of [18F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function
3. Image-based dosimetry for [225Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics
4. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies
5. Correction: Dual-targeted NIS polyplexes—a theranostic strategy toward tumors with heterogeneous receptor expression
6. Author Correction: Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
7. Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
8. Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
9. Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
10. [68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis
11. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
12. Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients
13. Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy
14. Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse model
15. Astroglial glucose uptake determines brain FDG-PET alterations and metabolic connectivity during healthy aging in mice
16. Quantitative assessment of cardiac 123iodo-metaiodobenzylguanidine SPECT/CT in patients with arrhythmogenic right ventricular cardiomyopathy: Novel insight in disease monitoring
17. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
18. Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE
19. Towards multicenter β-amyloid PET imaging in mouse models: A triple scanner head-to-head comparison
20. Good practices for the automated production of 18F-SiFA radiopharmaceuticals
21. Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS
22. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
23. The assessment of left ventricular volume and function in gated small animal 18F-FDG PET/CT imaging: a comparative study of three commercially available software tools
24. Depletion and activation of microglia impact metabolic connectivity of the mouse brain
25. Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
26. [18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
27. Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition
28. Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria
29. TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma
30. Silicon–Fluoride Acceptors (SiFA) for 18F-Radiolabeling: From Bench to Bedside
31. Aktuelle nuklearmedizinische Entwicklungen beim fortgeschrittenen Nierenzellkarzinom
32. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients
33. Tau deposition patterns are associated with functional connectivity in primary tauopathies
34. Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy
35. Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients
36. Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
37. Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
38. Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy
39. Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment
40. Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
41. PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
42. Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy
43. TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
44. Detection of apoptosis by [18F]ML-10 after cardiac ischemia–reperfusion injury in mice
45. Combination of pre-treatment dynamic [18F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
46. Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
47. Acetyl-dl-leucine in cerebellar ataxia ([18F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks?
48. The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy—a multicenter retrospective analysis
49. Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
50. Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.